Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease ; day:6 ; month:9 ; year:2018 ; pages:1-11
Acta neuropathologica ; (6.9.2018), 1-11
- Urheber
-
Pickett, Eleanor K.
- Beteiligte Personen und Organisationen
-
Rose, Jamie
McCrory, Caoimhe
McKenzie, Chris-Anne
King, Declan
Smith, Colin
Gillingwater, Thomas H.
Henstridge, Christopher M.
Spires-Jones, Tara L.
SpringerLink (Online service)
- DOI
-
10.1007/s00401-018-1903-2
- URN
-
urn:nbn:de:101:1-2018102419392464714684
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pickett, Eleanor K.
- Rose, Jamie
- McCrory, Caoimhe
- McKenzie, Chris-Anne
- King, Declan
- Smith, Colin
- Gillingwater, Thomas H.
- Henstridge, Christopher M.
- Spires-Jones, Tara L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Role of BACE1 in Alzheimer’s synaptic function
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Alzheimer's disease: synaptic dysfunction and Aβ
Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia
Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Role of BACE1 in Alzheimer’s synaptic function
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Alzheimer's disease: synaptic dysfunction and Aβ
Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia
Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Role of BACE1 in Alzheimer’s synaptic function
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Alzheimer's disease: synaptic dysfunction and Aβ
Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia